HER2 Support Group Forums - View Single Post - Dr. Slamon's 10-6-11 NEJM review on Herceptin

her2 newBEE · 02-16-2012, 11:32 AM

Hi Chrisy...really curious what your onc thinks about this with regard to MM-302. I can only guess that an anthracyline attached to Trastuzumab/Her2 targeted agent would have less systemic toxicity than a standard anthracycline regimen???

02-16-2012, 11:32 AM	#5
her2 newBEE Member Join Date: Apr 2011 Posts: 15	Re: Dr. Slamon's 10-6-11 NEJM review on Herceptin Hi Chrisy...really curious what your onc thinks about this with regard to MM-302. I can only guess that an anthracyline attached to Trastuzumab/Her2 targeted agent would have less systemic toxicity than a standard anthracycline regimen???